Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/1998
06/02/1998US5759856 Co-culture of immortalized cell which expresses a factor needed by another cell in the culture, interleukins
06/02/1998US5759855 Methods for modifying the binding activity of cell adhesion receptors
06/02/1998US5759854 Protein
06/02/1998US5759853 Coding, promoter and regulator sequences of IRF-1
06/02/1998US5759852 Expression vector containing PL6M promoter and TAT32 ribosome binding site and host cells transformed therewith
06/02/1998US5759841 Immunological composition of measles virus utilizing recombinant poxvirus
06/02/1998US5759837 Antitumor agents and anticarcinogenic agents
06/02/1998US5759834 Synthetic polypeptide as catalyst
06/02/1998US5759828 Cyclic di-guanylate metabolic enzymes
06/02/1998US5759819 From recombinant host, yeast, controlling temperature to improve yield, reduce color
06/02/1998US5759818 N-terminal CTP extended pharmaceutical peptides and proteins
06/02/1998US5759817 Heterodimeric receptor libraries using phagemids
06/02/1998US5759816 Bovine growth hormone with restriction mapping and plasmids
06/02/1998US5759815 Production of platelet derived growth factor (PDGF) an muteins thereof
06/02/1998US5759814 Genetic engineering and dna for gene expression of glucosylated polypeptides in eukarotic host cells, oligonucleotide sequences, transcription and translational regulatory sequences and transformation
06/02/1998US5759813 Methods and compositions relating to useful antigens of moraxella catarrhalis
06/02/1998US5759812 Human selenium-binding protein
06/02/1998US5759811 Mutant human hedgehog gene
06/02/1998US5759810 Method for secretory production of protein
06/02/1998US5759809 Methods of expressing proteins in insect cells and methods of killing insects
06/02/1998US5759808 Immunoglobulins devoid of light chains
06/02/1998US5759807 Process for producing relaxin
06/02/1998US5759806 Coding, promoter and regulator sequences of IRF-1
06/02/1998US5759805 Recombinant polynucleotides that regulate transcription and expression of coding sequences
06/02/1998US5759804 Culture product
06/02/1998US5759803 Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA
06/02/1998US5759802 Production of human serum alubumin A
06/02/1998US5759801 Δ5,7 -sterol reductase from arabidopsis thaliana
06/02/1998US5759792 Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against the same
06/02/1998US5759791 Kits for diagnosis of breast cancer using antibodies
06/02/1998US5759790 Von Hippel - Lindau (VHL) disease gene and corresponding cDNA and methods for detecting carriers of the VHL disease gene
06/02/1998US5759789 Prostaglandin receptor EP2
06/02/1998US5759788 High affinity L-proline transporter polypeptides; antibodies and immunoassays specific for them
06/02/1998US5759783 Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene
06/02/1998US5759782 Cellular apoptosis susceptibility protein (CSP) and antisense CSP
06/02/1998US5759776 Targets for breast cancer diagnosis and treatment
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759770 Retrovirus from the HIV group and its use
06/02/1998US5759769 Diagnostic kits, vaccines; immobilized peptide having amino acid sequence epitope
06/02/1998US5759551 Luteinizing hormone releasing hormone peptides that prevent growth of the prostate gland
06/02/1998US5759547 Methods and compositions for treatment of angiogenic diseases
06/02/1998US5759546 Treatment of CD4 T-cell mediated conditions
06/02/1998US5759542 Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
06/02/1998US5759538 Bacillus thuringiensis apr and npr genes, apr and npr B.t. strains, and method of use
06/02/1998US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses
06/02/1998US5759535 Immunotherapeutic strategies for the treatment of cancer
06/02/1998US5759533 Neutrophil-activating peptide-2
06/02/1998US5759517 Hemoglobins as drug delivery agents
06/02/1998US5759516 Peptide-metal ion pharmaceutical preparation
06/02/1998US5759515 Polyvalent peptide pharmaceutical applications
06/02/1998CA1339894C Fusion proteins with a eukaryotic ballast portion
06/02/1998CA1339892C Preparation of polypeptides having human gamma enterferon activity
05/1998
05/29/1998CA2222483A1 Composition for treating cornea
05/28/1998WO1998022942A1 Magnetizable device
05/28/1998WO1998022619A1 Metal mediated serine protease inhibitors
05/28/1998WO1998022617A1 Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer
05/28/1998WO1998022609A1 Chimeric adenoviral vectors
05/28/1998WO1998022608A2 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
05/28/1998WO1998022606A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022596A1 RECOMBINANT VACCINIA VIRUS, PROCESS FOR PREPARING Gag PROTEIN PARTICLE STRUCTURE USING THE SAME, PARTICLE PREPARED BY SAID PROCESS, AND USE THEREOF
05/28/1998WO1998022595A1 Broad-spectrum delta-endotoxins
05/28/1998WO1998022594A1 Compositions and methods for plant pathogen resistance
05/28/1998WO1998022591A2 Carrot antifreeze polypeptides
05/28/1998WO1998022589A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998WO1998022588A2 An improved method for the production and purification of adenoviral vectors
05/28/1998WO1998022587A2 Pituitary-tumor-transforming-genes, and related products
05/28/1998WO1998022586A2 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR
05/28/1998WO1998022585A1 HUMAN POLYHOMEOTIC 2(hph2) ACTS AS AN ONCOGENE
05/28/1998WO1998022584A1 C1q RECEPTOR, ENCODING GENE AND APPLICATION IN HOST DEFENSE ENHANCEMENT
05/28/1998WO1998022583A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION
05/28/1998WO1998022582A1 Human cancer regression antigen protein
05/28/1998WO1998022581A1 Transcription repressor
05/28/1998WO1998022580A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
05/28/1998WO1998022577A1 Fusion proteins having increased half-lives
05/28/1998WO1998022575A2 Nucleotide sequence of escherichia coli pathogenicity islands
05/28/1998WO1998022509A1 Monoclonal antibodies specific for the psa-act complex
05/28/1998WO1998022507A2 Receptor tyrosine kinase genes
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998WO1998022505A1 Soluble polypeptides
05/28/1998WO1998022504A1 Novel semaphorin genes (i)
05/28/1998WO1998022503A2 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto-immune antibodies
05/28/1998WO1998022502A1 Gene product over expressed in cancer cells
05/28/1998WO1998022501A2 Secreted proteins and polynucleotides encoding them
05/28/1998WO1998022500A2 Modulation of interactions between myosin and integrins
05/28/1998WO1998022499A2 Arretin, a neurite outgrowth modulator, antibodies thereto and uses thereof
05/28/1998WO1998022492A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998WO1998022441A2 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
05/28/1998WO1998022430A1 N-(ARYL/HETEROARYLACETYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING b-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
05/28/1998WO1998022146A2 Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infra-red radiation (nir radiation)
05/28/1998WO1998022145A1 Immunization of infants
05/28/1998WO1998022143A1 Chimeric retrovirus/adenovirus system
05/28/1998WO1998022140A2 Hybrid compositions for intracellular targeting
05/28/1998WO1998022139A1 Detection of galectin-4 in human tumors
05/28/1998WO1998022138A1 Method for treating symptoms of diabetes
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022122A1 Alkyl peptide amides and applications
05/28/1998WO1998022120A1 Diagnostic and therapeutic reagents for alzheimer's disease
05/28/1998WO1998021972A2 Compounds with improved inductive effect on cartilage and bones
05/28/1998WO1998021938A1 Glutathione-s-conjugate transport in plants
1 ... 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 ... 2916